Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC20961	AA-861	AA-861 (Docebenone) is a potent, selective 5-Lipoxygenase (5-LO) inhibitor with IC50 of 0.8 uM.
DC26090	AAD777	AAD777 (NVP-AAD777.
DC20618	AAI-101 Featured	AAI-101 is a novel extended-spectrum β-lactamase inhibitor with activity against many β-lactamases, including some class A and class D carbapenemases.
DC12566	AAK1 inhibitor 1	AAK1 inhibitor 1 (SGC-AAK1-1) is a potent, selective inhibitor of AAK1 and BMP2K/BIKE ((BMP-2 inducible kinase)) that potently targets the ATP-binding site (AAK1 Ki =9.1 nM, BIKE Ki= 17 nM).
DC21862	AAK1 inhibitor 25A	AAK1 inhibitor 25A is a potent, selective inhibitor of AAK1 and the closely related kinase BMP2K with Ki of 8 nM (AAK1).
DC12400	AAL(S)	AAL(S) is the chiral deoxy analog of the FDA approved drug FTY720, has been shown to inhibit proliferation and apoptosis in several cancer cell lines by activating protein phosphatase 2A (PP2A)..
DC23864	AAL993 Featured	AAL993 (ZK260253) is a potent, orally active VEGFR inhibitor with IC50 of 130, 23 and 18 nM for VEGFR-1, 2 and 3, respectively.
DC21981	CD73 inhibitor AB-680 Featured	AB680 (AB-680) is a highly potent, selective, reversible inhibitor of CD73 with Ki/IC50 of 4.9/70 pM (hCD73), displays > 10,000-fold selectivity against related ecto-nucleotidases (CD39, NTPDases 2/3/8) and a large panel of unrelated enzymes, receptors, a
DC8161	Xeglyze(Abametapir) Featured	Abametapir is the active ingredient of Xeglyze Lotion.
DC12444	ABD-1970	ABD-1970 (ABD1970) is a highly potent, selective Monoacylglycerol lipase (MGLL) inhibitor with IC50 of 13 nM (human MGLL).
DC20620	ABD345	ABD345 is a small molecule inhibitor of RANKL signalling, inhibits TNF-induced NF-κB and MAPK activation and inflammation.
DC23586	Abeprazan	Abeprazan is an acid pump inhibitor..
DC24211	Abiraterone (D4A) Featured	Abiraterone (D4A) is an active metabolite of the CYP17A1 inhibitor abiraterone.
DC20619	ABL127 Featured	ABL127 (ML174) is a potent, selective, covalent inhibitor of protein methylesterase 1 (PME-1) with IC50 of 10 nM.
DC20298	ABL-IN-29	ABL-IN-29 is a picomolar ABL kinase inhibitor with IC50 of 0.06/0.11 nM for wt ABL and ABL T315I respectively..
DC20299	ABMA	ABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite.
DC21983	Abn-CBD	Abn-CBD (Abnormal Cannabidiol) is a selective agonist of GPR55 receptor with EC50 of 2.5 uM, shows no significant activity against CB1 and CB2 receptors (EC50>30 uM).
DC20625	ABT-072	ABT-072 is a novel, orally bioavailable non-nucleoside HCV NS5B polymerase inhibitor with EC50 of 0.3 nM (GT1b).
DC22258	ABT-080	ABT-080 is a potent FLAP inhibitor that inhibits ionophore-stimulated LTB(4) formation with with IC50 of 20 nM.
DC20626	ABT-089	ABT-089 (Pozanicline) is a potent, selective α4β2 nAChR agonist with Ki of 16 nM.
DC21984	ABT-100	ABT-100 (ABT100) is a highly selective, potent, orally bioavailable inhibitor of farnesyltransferase (FTase).
DC20628	ABT-102	ABT-102 is a potent, highly selective, orally active TRPV1 antagonist that inhibits agonist-evoked increases in intracellular Ca(2+) levels with IC50 of 5-7 nM.
DC20629	ABT-107	ABT-107 is a potent and selective α7 nAChR agonist with Ki of 0.2-0.6 nM for rat or human cortex α7 nAChRs.
DC23537	ABT-288	ABT-288 is a potent, selective and competitive antagonist of H3 receptor with Ki of 1.9/8.2 nM for human/rat H3 respectively.
DC7352	ABT-333 Featured	ABT-333 is an NS5B non-nucleoside polymerase inhibitor.
DC10049	Tebanicline(ABT-594) Featured	ABT-594 represents a novel class of broad-spectrum analgesics whose primary mechanism of action is activation of the neuronal nicotinic acetylcholine receptors.
DC10723	ABT-702 Featured	ABT-702 is a potent non-nucleoside adenosine kinase inhibitor (IC50 = 1.7 nM), selective over other sites of adenosine interaction (A1, A2A and A3 receptors, adenosine transporter and adenosine deaminase).
DC9262	ABT-719 Featured	ABT-719 is a potent bacterial DNA gyrase inhibitor.
DC9261	ABT-719 HCl Featured	ABT-719 is a potent bacterial DNA gyrase inhibitor.
DC20630	ABTL0812	ABTL0812 is a novel first-in-class, small molecule that inhibits the Akt/mTORC1 axis and shows antiproliferative effect on tumor cells.

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.